Trial Profile
INDUCTION AND MAINTENANCE OF MUCOSAL HEALING IN CROHN'S DISEASE WITH USTEKINUMAB IN CLINICAL PRACTICE
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Sep 2023
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary) ; Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms MUCUS
- 12 Sep 2023 Planned number of patients changed from 100 to 60.
- 08 Mar 2023 Status changed from recruiting to completed.
- 27 Sep 2018 New trial record